MiMedx, Sanara receive FTC request for additional information on merger
MDXG•MiMedx and Sanara MedTech received FTC requests for additional information on October 15, 2026, extending the waiting period for their proposed merger. The waiting period will run until 30 days after substantial compliance unless it is extended by the parties or ended earlier by the FTC.
1. FTC review extends waiting period
MiMedx and Sanara MedTech received FTC requests for additional information on October 15, 2026, extending the waiting period for their proposed merger. The waiting period runs until 30 days following substantial compliance, unless the parties voluntarily extend it or the FTC ends it earlier. Sanara would become a wholly owned subsidiary, and closing remains subject to expiration or termination of the waiting period and other closing conditions.
